|
TMEM55B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13329999999567E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.61622000000028E-05 |
| Normal-vs-Stage2 |
7.75020000000071E-05 |
| Normal-vs-Stage3 |
5.552300E-02 |
| Normal-vs-Stage4 |
1.207930E-04 |
| Stage1-vs-Stage2 |
4.670400E-01 |
| Stage1-vs-Stage3 |
3.667600E-01 |
| Stage1-vs-Stage4 |
4.471800E-02 |
| Stage2-vs-Stage3 |
2.197200E-01 |
| Stage2-vs-Stage4 |
2.247000E-01 |
| Stage3-vs-Stage4 |
7.780200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.93887999999642E-05 |
| Normal-vs-AfricanAmerican |
1.627300E-04 |
| Normal-vs-Asian |
1.245610E-02 |
| Caucasian-vs-AfricanAmerican |
6.377000E-01 |
| Caucasian-vs-Asian |
6.388800E-01 |
| AfricanAmerican-vs-Asian |
4.880400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.993280E-04 |
| Normal-vs-Female |
3.77019999997508E-07 |
| Male-vs-Female |
3.602400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.63335999999736E-05 |
| Normal-vs-Extreme_Weight |
8.189200E-04 |
| Normal-vs-Obese |
1.916680E-03 |
| Normal-vs-Extreme_Obese |
4.724800E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.111560E-01 |
| Normal_Weight-vs-Obese |
1.578630E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.850400E-01 |
| Extreme_Weight-vs-Obese |
9.633800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.998200E-01 |
| Obese-vs-Extreme_Obese |
6.429400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.176100E-02 |
| Normal-vs-Age(41-60Yrs) |
8.047500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.41880000004146E-06 |
| Normal-vs-Age(81-100Yrs) |
1.319150E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.027200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.234640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.668570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.028410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.925600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.729200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.984200E-04 |
| Normal-VS-Type2 PRCC |
2.400300E-04 |
| Normal-VS-KIRP CIMP |
3.51219999999985E-05 |
| Normal-VS-Unclassified PRCC |
1.817540E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.388790E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.296700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.960970E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.180560E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.615800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.429500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.86940000000458E-05 |
| Normal-vs-N1 |
1.789530E-04 |
| Normal-vs-N2 |
5.8616999999983E-05 |
| N0-vs-N1 |
8.540800E-01 |
| N0-vs-N2 |
5.271700E-02 |
| N1-vs-N2 |
5.059500E-02 |
|
|
